ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 966,73
1,71%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Actualités

LQDA Liquidia Corporation

12,79
-0,19 (-1,46%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Liquidia Corporation LQDA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,19 -1,46% 12,79 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
13,15 12,66 13,23 12,79 12,98
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202415:00GLOBELiquidia Corporation to Present at 23rd Annual Needham..
01/4/202412:00GLOBEUpdate on Favorable Legal and Regulatory Outcomes Clearing..
13/3/202411:00GLOBELiquidia Corporation Reports Full Year 2023 Financial..
06/3/202412:30GLOBELiquidia Corporation to Report Full Year 2023 Financial..
05/3/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202412:30GLOBELiquidia Corporation Announces Poster Presentation at the..
25/1/202413:01EDGAR2Form 8-K - Current report
25/1/202412:00GLOBELiquidia Corporation Provides Update on New Drug Application..
23/1/202413:30EDGAR2Form 8-K - Current report
19/1/202413:01EDGAR2Form 8-K - Current report
19/1/202412:30GLOBELiquidia Corporation Announces Updates to Operations..
16/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202413:42EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202422:15EDGAR2Form 8-K - Current report
08/1/202414:22GLOBELiquidia Corporation Files Response to United Therapeutics..
05/1/202412:45GLOBELiquidia Provides Update on Clinical Pipeline Targeting PAH..
05/1/202403:37EDGAR2Form 8-K - Current report
04/1/202415:10GLOBELiquidia Corporation Announces $100 Million in New..
04/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202412:45GLOBELiquidia Corporation to Present at 42nd Annual J.P. Morgan..
28/12/202322:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/12/202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202323:16EDGAR2Form 8-K - Current report
20/12/202322:56GLOBEU.S. Federal Circuit Affirms Earlier PTAB Decision to..
19/12/202302:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:02EDGAR2Form 8-K - Current report
12/12/202322:41EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/12/202314:44EDGAR2Form 8-K - Current report
12/12/202313:13GLOBELiquidia Announces Pricing of Public Offering of Common..
12/12/202313:04EDGAR2Form 8-K - Current report
06/12/202303:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:30EDGAR2Form 8-K - Current report
07/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202312:36EDGAR2Form 8-K - Current report
07/11/202312:30GLOBELiquidia Corporation Reports Third Quarter 2023 Financial..
31/10/202311:30GLOBELiquidia Corporation to Report Third Quarter 2023 Financial..
02/10/202313:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
25/9/202323:00EDGAR2Form 8-K - Current report
25/9/202322:09GLOBEFDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
06/9/202322:37EDGAR2Form 8-K - Current report
06/9/202322:30GLOBEUnited Therapeutics Corporation Files Lawsuit Alleging..
06/9/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202312:00EDGAR2Form 8-K - Current report
10/8/202312:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202312:00GLOBELiquidia Corporation Reports Second Quarter 2023 Financial..
10/8/202312:00EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
LQDA
Liquidia
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés